Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers (Draft)-2022/11/1

Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) - Small Entity Compliance Guide (Final)-2022/11/1

Measuring Growth and Evaluating Pubertal Development in Pediatric Clinical Trials; Draft Guidance for Industry; Availability (Draft)-2022/10/31

Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention (Draft)-2022/10/27

Multiple Endpoints in Clinical Trials Guidance for Industry (Final)-2022/10/21

In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAs (Draft)-2022/10/21

In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs (Draft)-2022/10/21

Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs (Draft)-2022/10/21

Topical Dermatologic Corticosteroids: In Vivo Bioequivalence (Draft)-2022/10/21

Human Gene Therapy for Neurodegenerative Diseases (Final)-2022/10/21